Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxMinority InterestNon-Current AssetsOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Guardian Pharmacy Services (GRDN) Accumulated Expenses (2023 - 2025)

Guardian Pharmacy Services (GRDN) has disclosed Accumulated Expenses for 3 consecutive years, with $15.0 million as the latest value for Q4 2025.

  • Quarterly Accumulated Expenses rose 4.28% to $15.0 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $15.0 million through Dec 2025, up 4.28% year-over-year, with the annual reading at $15.0 million for FY2025, 4.28% up from the prior year.
  • Accumulated Expenses hit $15.0 million in Q4 2025 for Guardian Pharmacy Services, down from $15.9 million in the prior quarter.
  • In the past five years, Accumulated Expenses ranged from a high of $17.3 million in Q2 2025 to a low of $10.5 million in Q1 2025.
  • Historically, Accumulated Expenses has averaged $14.9 million across 3 years, with a median of $15.0 million in 2025.
  • Biggest five-year swings in Accumulated Expenses: dropped 14.92% in 2024 and later rose 14.25% in 2025.
  • Year by year, Accumulated Expenses stood at $17.0 million in 2023, then decreased by 14.92% to $14.4 million in 2024, then increased by 4.28% to $15.0 million in 2025.
  • Business Quant data shows Accumulated Expenses for GRDN at $15.0 million in Q4 2025, $15.9 million in Q3 2025, and $17.3 million in Q2 2025.